James T C Li, M.D., Ph.D.

Location

SUMMARY

James T C Li, M.D., Ph.D., studies the clinical relevance of drug hypersensitivity to beta-lactam antimicrobial agents. Clinical studies of these agents have resulted in a significant decrease in vancomycin use in people with a history of possible penicillin allergy.

Dr. Li is involved in clinical trials evaluating the pharmacological and immunologic treatment of asthma. He also has co-developed a survey instrument for the assessment of asthma control.

Focus areas

• Improving the diagnosis and management of drug allergies.
• Recognition and treatment of anaphylaxis.
• Refining the role of biological and immunologic therapy of severe asthma.
• Studying anaphylaxis in the emergency department.

Significance to patient care

Studies show that drug allergies can decrease over time. With the right review, many people can safely take medicines that used to cause reactions. Studies involving allergy shots and standardized guidelines can lead to successful allergy treatment and decreased injection reactions.

Professional highlights

• President's Award, American Academy of Allergy, Asthma and Immunology, 2022.
• President's Award, National Medical Association, 2015.